Additional information
White Powder
368451-10-9
ACI-023712
264.1-267.4°C
C24H28O3
364.48
Ambient
2-8°C
Anticancer
Pharmaceutical Impurity Standards
4-[1-(5,6,7,8-Tetrahydro-7-hydroxy-3,5,5,8,8-pentamethyl-2-naphthalenyl) ethenyl]benzoic Acid (7-Hydroxy Bexarotene)
4-[1-(5,6,7,8-Tetrahydro-7-hydroxy-3,5,5,8,8-pentamethyl-2-naphthalenyl) ethenyl]benzoic Acid
7-Hydroxy Bexarotene





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)